Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Initiation
Cogent Biosciences initiated with an Overweight at Piper Sandler » 04:51
12/23/20
12/23
04:51
12/23/20
04:51
COGT

Cogent Biosciences

$12.19 /

-0.19 (-1.53%)

, BPMC

Blueprint Medicines

$123.72 /

+2.23 (+1.84%)

Piper Sandler analyst…

Piper Sandler analyst Christopher Raymond initiated coverage of Cogent Biosciences (COGT) with an Overweight rating and $22 price target. The stock's risk/reward "skews meaningfully to the upside," Raymond tells investors in a research note. The company's PLX9486 can become standard of care in indolent systemic mastocytosis and may also serve as a treatment option in advanced gastrointestinal stromal tumors, says the analyst. Raymond sees a more favorable safety profile for PLX9486 compared to Blueprint Medicines' (BPMC) avapritinib and a "sizeable valuation gap."

ShowHide Related Items >><<
COGT Cogent Biosciences
$12.19 /

-0.19 (-1.53%)

BPMC Blueprint Medicines
$123.72 /

+2.23 (+1.84%)

COGT Cogent Biosciences
$12.19 /

-0.19 (-1.53%)

12/17/20 SVB Leerink
Cogent Biosciences initiated with an Outperform at SVB Leerink
11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
BPMC Blueprint Medicines
$123.72 /

+2.23 (+1.84%)

12/18/20 JMP Securities
Blueprint Medicines price target raised to $152 from $118 at JMP Securities
12/14/20 BMO Capital
Blueprint Medicines price target raised to $132 from $113 at BMO Capital
12/02/20 Stifel
Blueprint Medicines initiated with a Hold at Stifel
11/02/20 Jefferies
Jefferies cuts Blueprint to Hold with current products' potential priced in
COGT Cogent Biosciences
$12.19 /

-0.19 (-1.53%)

BPMC Blueprint Medicines
$123.72 /

+2.23 (+1.84%)

  • 02
    Dec
  • 23
    Jan
COGT Cogent Biosciences
$12.19 /

-0.19 (-1.53%)

Initiation
Cogent Biosciences initiated with an Outperform at SVB Leerink » 08:47
12/17/20
12/17
08:47
12/17/20
08:47
COGT

Cogent Biosciences

$10.95 /

+0.47 (+4.48%)

SVB Leerink analyst…

SVB Leerink analyst Christopher Liu initiated coverage of Cogent Biosciences with an Outperform rating and $20 price target.

ShowHide Related Items >><<
COGT Cogent Biosciences
$10.95 /

+0.47 (+4.48%)

COGT Cogent Biosciences
$10.95 /

+0.47 (+4.48%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
COGT Cogent Biosciences
$10.95 /

+0.47 (+4.48%)

  • 02
    Dec
COGT Cogent Biosciences
$10.95 /

+0.47 (+4.48%)

Over a month ago
Conference/Events
Evercore ISI to hold a virtual conference » 04:55
12/03/20
12/03
04:55
12/03/20
04:55
CMPS

Compass Pathways

$47.94 /

+3.21 (+7.18%)

, INSM

Insmed

$39.74 /

+0.71 (+1.82%)

, ALXN

Alexion

$122.70 /

+0.55 (+0.45%)

, ENTA

Enanta

$42.11 /

+1.06 (+2.58%)

, NKTX

Nkarta

$33.99 /

-0.02 (-0.06%)

, HRC

Hill-Rom

$96.12 /

-0.16 (-0.17%)

, DRNA

Dicerna

$24.45 /

-0.31 (-1.25%)

, ZBH

Zimmer Biomet

$147.88 /

+1.77 (+1.21%)

, INCY

Incyte

$82.30 /

-3.14 (-3.68%)

, MTEM

Molecular Templates

$8.68 /

-0.16 (-1.81%)

, KOD

Kodiak Sciences

$130.73 /

+0.35 (+0.27%)

, ICLR

Icon

$199.11 /

+1.67 (+0.85%)

, MCRB

Seres Therapeutics

$25.14 /

-1.2 (-4.56%)

, NVST

Envista

$31.12 /

+1.06 (+3.53%)

, EXEL

Exelixis

$19.32 /

+0.17 (+0.89%)

, FATE

Fate Therapeutics

$60.50 /

+0.35 (+0.58%)

, FOLD

Amicus

$23.25 /

+0.58 (+2.56%)

, COGT

Cogent Biosciences

$12.15 /

+1.63 (+15.49%)

, BHC

Bausch Health

$19.06 /

+0.42 (+2.25%)

, TBIO

Translate Bio

$22.49 /

+0.25 (+1.12%)

, STRO

Sutro Biopharma

$16.37 /

-0.4 (-2.39%)

, PRAX

Praxis Precision Medicines

$43.98 /

+1.51 (+3.56%)

3rd Annual HealthCONx…

3rd Annual HealthCONx Virtual Conference will be held on December 1-3.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$147.88 /

+1.77 (+1.21%)

TBIO Translate Bio
$22.49 /

+0.25 (+1.12%)

STRO Sutro Biopharma
$16.37 /

-0.4 (-2.39%)

PRAX Praxis Precision Medicines
$43.98 /

+1.51 (+3.56%)

NVST Envista
$31.12 /

+1.06 (+3.53%)

NKTX Nkarta
$33.99 /

-0.02 (-0.06%)

MTEM Molecular Templates
$8.68 /

-0.16 (-1.81%)

MCRB Seres Therapeutics
$25.14 /

-1.2 (-4.56%)

KOD Kodiak Sciences
$130.73 /

+0.35 (+0.27%)

INSM Insmed
$39.74 /

+0.71 (+1.82%)

INCY Incyte
$82.30 /

-3.14 (-3.68%)

ICLR Icon
$199.11 /

+1.67 (+0.85%)

HRC Hill-Rom
$96.12 /

-0.16 (-0.17%)

FOLD Amicus
$23.25 /

+0.58 (+2.56%)

FATE Fate Therapeutics
$60.50 /

+0.35 (+0.58%)

EXEL Exelixis
$19.32 /

+0.17 (+0.89%)

ENTA Enanta
$42.11 /

+1.06 (+2.58%)

DRNA Dicerna
$24.45 /

-0.31 (-1.25%)

COGT Cogent Biosciences
$12.15 /

+1.63 (+15.49%)

CMPS Compass Pathways
$47.94 /

+3.21 (+7.18%)

BHC Bausch Health
$19.06 /

+0.42 (+2.25%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

CMPS Compass Pathways
$47.94 /

+3.21 (+7.18%)

10/14/20 H.C. Wainwright
Compass Pathways initiated with a Buy at H.C. Wainwright
10/13/20 Evercore ISI
Compass Pathways initiated with an Outperform at Evercore ISI
10/13/20 Canaccord
Compass Pathways initiated with a Buy at Canaccord
10/13/20 Berenberg
Compass Pathways initiated with a Buy at Berenberg
INSM Insmed
$39.74 /

+0.71 (+1.82%)

11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
10/12/20 Stifel
Insmed resumed with a Buy at Stifel
04/23/20 JMP Securities
JMP reiterates $50 target on Insmed on planned COVID-19 trial
ALXN Alexion
$122.70 /

+0.55 (+0.45%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/19/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/05/20 Citi
Alexion price target raised to $157 from $145 at Citi
ENTA Enanta
$42.11 /

+1.06 (+2.58%)

11/24/20 RBC Capital
Enanta price target lowered to $45 from $52 at RBC Capital
11/24/20 Evercore ISI
Evercore cautious on Enanta into 2021, starts with Underperform
11/23/20 Evercore ISI
Enanta initiated with an Underperform at Evercore ISI
10/26/20 Roth Capital
Enanta price target raised to $107 from $104 at Roth Capital
NKTX Nkarta
$33.99 /

-0.02 (-0.06%)

10/06/20 Mizuho
Nkarta CFO departure should not impact shares, says Mizuho
08/04/20 Mizuho
Mizuho starts Nkarta with Buy rating, $34 price target
08/04/20 Evercore ISI
Nkarta initiated with an Outperform at Evercore ISI
08/04/20 Stifel
Nkarta initiated with a Buy at Stifel
HRC Hill-Rom
$96.12 /

-0.16 (-0.17%)

11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
11/04/20 Needham
Hill-Rom downgraded to Hold from Buy at Needham
10/01/20 KeyBanc
Hill-Rom price target lowered to $115 from $138 at KeyBanc
DRNA Dicerna
$24.45 /

-0.31 (-1.25%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
ZBH Zimmer Biomet
$147.88 /

+1.77 (+1.21%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
INCY Incyte
$82.30 /

-3.14 (-3.68%)

11/06/20 RBC Capital
Incyte price target lowered to $86 from $96 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
MTEM Molecular Templates
$8.68 /

-0.16 (-1.81%)

09/08/20 Jefferies
Molecular Templates initiated with a Buy at Jefferies
08/07/20
Molecular Templates files $300M mixed securities shelf
05/12/20 Oppenheimer
Molecular Templates price target raised to $22 from $16 at Oppenheimer
03/25/20
Fly Intel: Top five analyst initiations
KOD Kodiak Sciences
$130.73 /

+0.35 (+0.27%)

11/30/20
Fly Intel: Top five analyst downgrades
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral on valuation at JPMorgan
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral from Overweight at JPMorgan
11/16/20 Morgan Stanley
Morgan Stanley downgrades Kodiak to Equal Weight on lack of near-term catalysts
ICLR Icon
$199.11 /

+1.67 (+0.85%)

10/23/20 Deutsche Bank
Icon price target raised to $179 from $170 at Deutsche Bank
10/23/20 Mizuho
Icon price target raised to $217 from $195 at Mizuho
10/22/20 Credit Suisse
Icon price target raised to $235 from $230 at Credit Suisse
07/27/20 Truist
SunTrust raises price targets on select late-stage CROs
MCRB Seres Therapeutics
$25.14 /

-1.2 (-4.56%)

11/09/20 Oppenheimer
Seres Therapeutics price target raised to $38 from $34 at Oppenheimer
11/09/20 Piper Sandler
Seres Therapeutics price target raised to $49 from $40 at Piper Sandler
10/27/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
10/26/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
NVST Envista
$31.12 /

+1.06 (+3.53%)

10/30/20 JPMorgan
Envista price target raised to $30 from $28 at JPMorgan
10/30/20 Piper Sandler
Envista price target raised to $28 from $22 at Piper Sandler
07/31/20 Piper Sandler
Envista price target raised to $22 from $20 at Piper Sandler
06/16/20
Fly Intel: Top five analyst initiations
EXEL Exelixis
$19.32 /

+0.17 (+0.89%)

10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
FATE Fate Therapeutics
$60.50 /

+0.35 (+0.58%)

12/02/20 Barclays
Fate Therapeutics price target raised to $70 from $60 at Barclays
11/24/20 Truist
Fate Therapeutics price target raised to $65 from $40 at Truist
11/09/20 Citi
Fate Therapeutics price target raised to $63 from $40 at Citi
11/08/20 Oppenheimer
Fate Therapeutics price target raised to $60 from $40 at Oppenheimer
FOLD Amicus
$23.25 /

+0.58 (+2.56%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Amicus initiated with a Hold at Berenberg
11/06/20 Baird
Amicus price target raised to $25 from $20 at Baird
08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
COGT Cogent Biosciences
$12.15 /

+1.63 (+15.49%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
BHC Bausch Health
$19.06 /

+0.42 (+2.25%)

11/05/20 Piper Sandler
Bausch Health price target lowered to $25 from $26 at Piper Sandler
10/26/20 Barclays
Bausch Health price target raised to $29 from $28 at Barclays
09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
TBIO Translate Bio
$22.49 /

+0.25 (+1.12%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
07/07/20 H.C. Wainwright
Translate Bio price target raised to $32 from $18 at H.C. Wainwright
07/06/20
Fly Intel: Top five analyst initiations
07/06/20 William Blair
Translate Bio initiated with an Outperform at William Blair
STRO Sutro Biopharma
$16.37 /

-0.4 (-2.39%)

12/02/20 Stifel
Sutro Biopharma initiated with a Buy at Stifel
11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/02/20 Jefferies
Sutro Biopharma initiated with a Buy at Jefferies
PRAX Praxis Precision Medicines
$43.98 /

+1.51 (+3.56%)

11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
11/11/20 Wedbush
Praxis Precision Medicines initiated with an Outperform at Wedbush
ZBH Zimmer Biomet
$147.88 /

+1.77 (+1.21%)

STRO Sutro Biopharma
$16.37 /

-0.4 (-2.39%)

NVST Envista
$31.12 /

+1.06 (+3.53%)

MTEM Molecular Templates
$8.68 /

-0.16 (-1.81%)

MCRB Seres Therapeutics
$25.14 /

-1.2 (-4.56%)

KOD Kodiak Sciences
$130.73 /

+0.35 (+0.27%)

INSM Insmed
$39.74 /

+0.71 (+1.82%)

INCY Incyte
$82.30 /

-3.14 (-3.68%)

ICLR Icon
$199.11 /

+1.67 (+0.85%)

HRC Hill-Rom
$96.12 /

-0.16 (-0.17%)

FOLD Amicus
$23.25 /

+0.58 (+2.56%)

FATE Fate Therapeutics
$60.50 /

+0.35 (+0.58%)

EXEL Exelixis
$19.32 /

+0.17 (+0.89%)

ENTA Enanta
$42.11 /

+1.06 (+2.58%)

DRNA Dicerna
$24.45 /

-0.31 (-1.25%)

COGT Cogent Biosciences
$12.15 /

+1.63 (+15.49%)

CMPS Compass Pathways
$47.94 /

+3.21 (+7.18%)

BHC Bausch Health
$19.06 /

+0.42 (+2.25%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

  • 02
    Dec
  • 18
    Nov
  • 16
    Oct
  • 18
    Sep
  • 13
    Aug
  • 10
    Jul
  • 26
    Jun
  • 09
    Jun
  • 12
    May
  • 05
    May
  • 04
    Dec
TBIO Translate Bio
$22.49 /

+0.25 (+1.12%)

FOLD Amicus
$23.25 /

+0.58 (+2.56%)

CMPS Compass Pathways
$47.94 /

+3.21 (+7.18%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

TBIO Translate Bio
$22.49 /

+0.25 (+1.12%)

STRO Sutro Biopharma
$16.37 /

-0.4 (-2.39%)

PRAX Praxis Precision Medicines
$43.98 /

+1.51 (+3.56%)

NVST Envista
$31.12 /

+1.06 (+3.53%)

NKTX Nkarta
$33.99 /

-0.02 (-0.06%)

MTEM Molecular Templates
$8.68 /

-0.16 (-1.81%)

MCRB Seres Therapeutics
$25.14 /

-1.2 (-4.56%)

KOD Kodiak Sciences
$130.73 /

+0.35 (+0.27%)

FOLD Amicus
$23.25 /

+0.58 (+2.56%)

ENTA Enanta
$42.11 /

+1.06 (+2.58%)

COGT Cogent Biosciences
$12.15 /

+1.63 (+15.49%)

BHC Bausch Health
$19.06 /

+0.42 (+2.25%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

STRO Sutro Biopharma
$16.37 /

-0.4 (-2.39%)

MCRB Seres Therapeutics
$25.14 /

-1.2 (-4.56%)

INCY Incyte
$82.30 /

-3.14 (-3.68%)

CMPS Compass Pathways
$47.94 /

+3.21 (+7.18%)

BHC Bausch Health
$19.06 /

+0.42 (+2.25%)

ALXN Alexion
$122.70 /

+0.55 (+0.45%)

Syndicate
Cogent Biosciences 10.256M share Secondary priced at $9.75 » 06:09
12/02/20
12/02
06:09
12/02/20
06:09
COGT

Cogent Biosciences

$10.52 /

+0.56 (+5.62%)

The deal size was…

The deal size was increased to $100M in common stock from $60M in common stock. Jefferies and Piper Sandler acted as joint book running managers for the offering.

ShowHide Related Items >><<
COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

  • 02
    Dec
COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

Conference/Events
Evercore ISI to hold a virtual conference » 04:55
12/02/20
12/02
04:55
12/02/20
04:55
CMPS

Compass Pathways

$44.73 /

-4.78 (-9.65%)

, INSM

Insmed

$39.05 /

+0.03 (+0.08%)

, ALXN

Alexion

$122.16 /

+0.19 (+0.16%)

, ENTA

Enanta

$41.12 /

+0.01 (+0.02%)

, NKTX

Nkarta

$34.02 /

+1.09 (+3.31%)

, HRC

Hill-Rom

$96.26 /

+1.325 (+1.40%)

, DRNA

Dicerna

$24.76 /

-0.53 (-2.10%)

, ZBH

Zimmer Biomet

$146.00 /

-3.175 (-2.13%)

, INCY

Incyte

$85.42 /

+0.9 (+1.06%)

, MTEM

Molecular Templates

$8.85 /

-0.1 (-1.12%)

, KOD

Kodiak Sciences

$130.37 /

-6.31 (-4.62%)

, ICLR

Icon

$197.44 /

+2.59 (+1.33%)

, MCRB

Seres Therapeutics

$26.34 /

-1.2 (-4.36%)

, NVST

Envista

$30.06 /

+0.31 (+1.04%)

, EXEL

Exelixis

$19.15 /

+0.02 (+0.10%)

, FATE

Fate Therapeutics

$60.15 /

+1.68 (+2.87%)

, FOLD

Amicus

$22.66 /

-0.28 (-1.22%)

, COGT

Cogent Biosciences

$10.52 /

+0.56 (+5.62%)

, BHC

Bausch Health

$18.65 /

+0.065 (+0.35%)

, TBIO

Translate Bio

$22.25 /

+0.03 (+0.14%)

, STRO

Sutro Biopharma

$16.76 /

-0.32 (-1.87%)

, PRAX

Praxis Precision Medicines

$42.43 /

+1.49 (+3.64%)

3rd Annual HealthCONx…

3rd Annual HealthCONx Virtual Conference will be held on December 1-3.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

TBIO Translate Bio
$22.25 /

+0.03 (+0.14%)

STRO Sutro Biopharma
$16.76 /

-0.32 (-1.87%)

PRAX Praxis Precision Medicines
$42.43 /

+1.49 (+3.64%)

NVST Envista
$30.06 /

+0.31 (+1.04%)

NKTX Nkarta
$34.02 /

+1.09 (+3.31%)

MTEM Molecular Templates
$8.85 /

-0.1 (-1.12%)

MCRB Seres Therapeutics
$26.34 /

-1.2 (-4.36%)

KOD Kodiak Sciences
$130.37 /

-6.31 (-4.62%)

INSM Insmed
$39.05 /

+0.03 (+0.08%)

INCY Incyte
$85.42 /

+0.9 (+1.06%)

ICLR Icon
$197.44 /

+2.59 (+1.33%)

HRC Hill-Rom
$96.26 /

+1.325 (+1.40%)

FOLD Amicus
$22.66 /

-0.28 (-1.22%)

FATE Fate Therapeutics
$60.15 /

+1.68 (+2.87%)

EXEL Exelixis
$19.15 /

+0.02 (+0.10%)

ENTA Enanta
$41.12 /

+0.01 (+0.02%)

DRNA Dicerna
$24.76 /

-0.53 (-2.10%)

COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

CMPS Compass Pathways
$44.73 /

-4.78 (-9.65%)

BHC Bausch Health
$18.65 /

+0.065 (+0.35%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

CMPS Compass Pathways
$44.73 /

-4.78 (-9.65%)

10/14/20 H.C. Wainwright
Compass Pathways initiated with a Buy at H.C. Wainwright
10/13/20 Evercore ISI
Compass Pathways initiated with an Outperform at Evercore ISI
10/13/20 Canaccord
Compass Pathways initiated with a Buy at Canaccord
10/13/20 Berenberg
Compass Pathways initiated with a Buy at Berenberg
INSM Insmed
$39.05 /

+0.03 (+0.08%)

11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
10/12/20 Stifel
Insmed resumed with a Buy at Stifel
04/23/20 JMP Securities
JMP reiterates $50 target on Insmed on planned COVID-19 trial
ALXN Alexion
$122.16 /

+0.19 (+0.16%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/19/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/05/20 Citi
Alexion price target raised to $157 from $145 at Citi
ENTA Enanta
$41.12 /

+0.01 (+0.02%)

11/24/20 RBC Capital
Enanta price target lowered to $45 from $52 at RBC Capital
11/24/20 Evercore ISI
Evercore cautious on Enanta into 2021, starts with Underperform
11/23/20 Evercore ISI
Enanta initiated with an Underperform at Evercore ISI
10/26/20 Roth Capital
Enanta price target raised to $107 from $104 at Roth Capital
NKTX Nkarta
$34.02 /

+1.09 (+3.31%)

10/06/20 Mizuho
Nkarta CFO departure should not impact shares, says Mizuho
08/04/20 Mizuho
Mizuho starts Nkarta with Buy rating, $34 price target
08/04/20 Evercore ISI
Nkarta initiated with an Outperform at Evercore ISI
08/04/20 Stifel
Nkarta initiated with a Buy at Stifel
HRC Hill-Rom
$96.26 /

+1.325 (+1.40%)

11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
11/04/20 Needham
Hill-Rom downgraded to Hold from Buy at Needham
10/01/20 KeyBanc
Hill-Rom price target lowered to $115 from $138 at KeyBanc
DRNA Dicerna
$24.76 /

-0.53 (-2.10%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
INCY Incyte
$85.42 /

+0.9 (+1.06%)

11/06/20 RBC Capital
Incyte price target lowered to $86 from $96 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
MTEM Molecular Templates
$8.85 /

-0.1 (-1.12%)

09/08/20 Jefferies
Molecular Templates initiated with a Buy at Jefferies
08/07/20
Molecular Templates files $300M mixed securities shelf
05/12/20 Oppenheimer
Molecular Templates price target raised to $22 from $16 at Oppenheimer
03/25/20
Fly Intel: Top five analyst initiations
KOD Kodiak Sciences
$130.37 /

-6.31 (-4.62%)

11/30/20
Fly Intel: Top five analyst downgrades
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral on valuation at JPMorgan
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral from Overweight at JPMorgan
11/16/20 Morgan Stanley
Morgan Stanley downgrades Kodiak to Equal Weight on lack of near-term catalysts
ICLR Icon
$197.44 /

+2.59 (+1.33%)

10/23/20 Deutsche Bank
Icon price target raised to $179 from $170 at Deutsche Bank
10/23/20 Mizuho
Icon price target raised to $217 from $195 at Mizuho
10/22/20 Credit Suisse
Icon price target raised to $235 from $230 at Credit Suisse
07/27/20 Truist
SunTrust raises price targets on select late-stage CROs
MCRB Seres Therapeutics
$26.34 /

-1.2 (-4.36%)

11/09/20 Oppenheimer
Seres Therapeutics price target raised to $38 from $34 at Oppenheimer
11/09/20 Piper Sandler
Seres Therapeutics price target raised to $49 from $40 at Piper Sandler
10/27/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
10/26/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
NVST Envista
$30.06 /

+0.31 (+1.04%)

10/30/20 JPMorgan
Envista price target raised to $30 from $28 at JPMorgan
10/30/20 Piper Sandler
Envista price target raised to $28 from $22 at Piper Sandler
07/31/20 Piper Sandler
Envista price target raised to $22 from $20 at Piper Sandler
06/16/20
Fly Intel: Top five analyst initiations
EXEL Exelixis
$19.15 /

+0.02 (+0.10%)

10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
FATE Fate Therapeutics
$60.15 /

+1.68 (+2.87%)

11/24/20 Truist
Fate Therapeutics price target raised to $65 from $40 at Truist
11/09/20 Citi
Fate Therapeutics price target raised to $63 from $40 at Citi
11/08/20 Oppenheimer
Fate Therapeutics price target raised to $60 from $40 at Oppenheimer
11/06/20 Piper Sandler
Fate Therapeutics price target raised to $71 from $59 at Piper Sandler
FOLD Amicus
$22.66 /

-0.28 (-1.22%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Amicus initiated with a Hold at Berenberg
11/06/20 Baird
Amicus price target raised to $25 from $20 at Baird
08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
BHC Bausch Health
$18.65 /

+0.065 (+0.35%)

11/05/20 Piper Sandler
Bausch Health price target lowered to $25 from $26 at Piper Sandler
10/26/20 Barclays
Bausch Health price target raised to $29 from $28 at Barclays
09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
TBIO Translate Bio
$22.25 /

+0.03 (+0.14%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
07/07/20 H.C. Wainwright
Translate Bio price target raised to $32 from $18 at H.C. Wainwright
07/06/20
Fly Intel: Top five analyst initiations
07/06/20 William Blair
Translate Bio initiated with an Outperform at William Blair
STRO Sutro Biopharma
$16.76 /

-0.32 (-1.87%)

11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/02/20 Jefferies
Sutro Biopharma initiated with a Buy at Jefferies
07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
PRAX Praxis Precision Medicines
$42.43 /

+1.49 (+3.64%)

11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
11/11/20 Wedbush
Praxis Precision Medicines initiated with an Outperform at Wedbush
ZBH Zimmer Biomet
$146.00 /

-3.175 (-2.13%)

STRO Sutro Biopharma
$16.76 /

-0.32 (-1.87%)

NVST Envista
$30.06 /

+0.31 (+1.04%)

MTEM Molecular Templates
$8.85 /

-0.1 (-1.12%)

MCRB Seres Therapeutics
$26.34 /

-1.2 (-4.36%)

KOD Kodiak Sciences
$130.37 /

-6.31 (-4.62%)

INSM Insmed
$39.05 /

+0.03 (+0.08%)

INCY Incyte
$85.42 /

+0.9 (+1.06%)

ICLR Icon
$197.44 /

+2.59 (+1.33%)

HRC Hill-Rom
$96.26 /

+1.325 (+1.40%)

FOLD Amicus
$22.66 /

-0.28 (-1.22%)

FATE Fate Therapeutics
$60.15 /

+1.68 (+2.87%)

EXEL Exelixis
$19.15 /

+0.02 (+0.10%)

ENTA Enanta
$41.12 /

+0.01 (+0.02%)

DRNA Dicerna
$24.76 /

-0.53 (-2.10%)

COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

CMPS Compass Pathways
$44.73 /

-4.78 (-9.65%)

BHC Bausch Health
$18.65 /

+0.065 (+0.35%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

  • 02
    Dec
  • 18
    Nov
  • 16
    Oct
  • 18
    Sep
  • 13
    Aug
  • 10
    Jul
  • 26
    Jun
  • 09
    Jun
  • 12
    May
  • 05
    May
  • 04
    Dec
TBIO Translate Bio
$22.25 /

+0.03 (+0.14%)

FOLD Amicus
$22.66 /

-0.28 (-1.22%)

CMPS Compass Pathways
$44.73 /

-4.78 (-9.65%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

TBIO Translate Bio
$22.25 /

+0.03 (+0.14%)

STRO Sutro Biopharma
$16.76 /

-0.32 (-1.87%)

PRAX Praxis Precision Medicines
$42.43 /

+1.49 (+3.64%)

NVST Envista
$30.06 /

+0.31 (+1.04%)

NKTX Nkarta
$34.02 /

+1.09 (+3.31%)

MTEM Molecular Templates
$8.85 /

-0.1 (-1.12%)

MCRB Seres Therapeutics
$26.34 /

-1.2 (-4.36%)

KOD Kodiak Sciences
$130.37 /

-6.31 (-4.62%)

FOLD Amicus
$22.66 /

-0.28 (-1.22%)

ENTA Enanta
$41.12 /

+0.01 (+0.02%)

COGT Cogent Biosciences
$10.52 /

+0.56 (+5.62%)

BHC Bausch Health
$18.65 /

+0.065 (+0.35%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

STRO Sutro Biopharma
$16.76 /

-0.32 (-1.87%)

MCRB Seres Therapeutics
$26.34 /

-1.2 (-4.36%)

INCY Incyte
$85.42 /

+0.9 (+1.06%)

CMPS Compass Pathways
$44.73 /

-4.78 (-9.65%)

BHC Bausch Health
$18.65 /

+0.065 (+0.35%)

ALXN Alexion
$122.16 /

+0.19 (+0.16%)

Conference/Events
Evercore ISI to hold a virtual conference » 08:22
12/01/20
12/01
08:22
12/01/20
08:22
CMPS

Compass Pathways

$49.60 /

+2.26 (+4.77%)

, INSM

Insmed

$39.02 /

-0.8 (-2.01%)

, ALXN

Alexion

$121.96 /

-2.03 (-1.64%)

, ENTA

Enanta

$41.32 /

-1.5 (-3.50%)

, NKTX

Nkarta

$32.91 /

-1.23 (-3.60%)

, HRC

Hill-Rom

$94.86 /

-0.71 (-0.74%)

, DRNA

Dicerna

$25.32 /

+0.79 (+3.22%)

, ZBH

Zimmer Biomet

$149.21 /

-0.79 (-0.53%)

, INCY

Incyte

$84.52 /

+1.33 (+1.60%)

, MTEM

Molecular Templates

$8.93 /

-0.18 (-1.98%)

, KOD

Kodiak Sciences

$136.67 /

+1.14 (+0.84%)

, ICLR

Icon

$194.85 /

+4.45 (+2.34%)

, MCRB

Seres Therapeutics

$27.58 /

-1.39 (-4.80%)

, NVST

Envista

$29.75 /

+0.14 (+0.47%)

, EXEL

Exelixis

$19.16 /

-0.26 (-1.34%)

, FATE

Fate Therapeutics

$58.47 /

+0.54 (+0.93%)

, FOLD

Amicus

$22.94 /

-0.31 (-1.33%)

, COGT

Cogent Biosciences

$10.02 /

+0.23 (+2.35%)

, BHC

Bausch Health

$18.58 /

-0.97 (-4.96%)

, TBIO

Translate Bio

$22.24 /

+2.9 (+14.99%)

, STRO

Sutro Biopharma

$17.08 /

-0.02 (-0.12%)

, PRAX

Praxis Precision Medicines

$40.94 /

+0.54 (+1.34%)

3rd Annual HealthCONx…

3rd Annual HealthCONx Virtual Conference will be held on December 1-3.

ShowHide Related Items >><<
ZBH Zimmer Biomet
$149.21 /

-0.79 (-0.53%)

TBIO Translate Bio
$22.24 /

+2.9 (+14.99%)

STRO Sutro Biopharma
$17.08 /

-0.02 (-0.12%)

PRAX Praxis Precision Medicines
$40.94 /

+0.54 (+1.34%)

NVST Envista
$29.75 /

+0.14 (+0.47%)

NKTX Nkarta
$32.91 /

-1.23 (-3.60%)

MTEM Molecular Templates
$8.93 /

-0.18 (-1.98%)

MCRB Seres Therapeutics
$27.58 /

-1.39 (-4.80%)

KOD Kodiak Sciences
$136.67 /

+1.14 (+0.84%)

INSM Insmed
$39.02 /

-0.8 (-2.01%)

INCY Incyte
$84.52 /

+1.33 (+1.60%)

ICLR Icon
$194.85 /

+4.45 (+2.34%)

HRC Hill-Rom
$94.86 /

-0.71 (-0.74%)

FOLD Amicus
$22.94 /

-0.31 (-1.33%)

FATE Fate Therapeutics
$58.47 /

+0.54 (+0.93%)

EXEL Exelixis
$19.16 /

-0.26 (-1.34%)

ENTA Enanta
$41.32 /

-1.5 (-3.50%)

DRNA Dicerna
$25.32 /

+0.79 (+3.22%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

CMPS Compass Pathways
$49.60 /

+2.26 (+4.77%)

BHC Bausch Health
$18.58 /

-0.97 (-4.96%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

CMPS Compass Pathways
$49.60 /

+2.26 (+4.77%)

10/14/20 H.C. Wainwright
Compass Pathways initiated with a Buy at H.C. Wainwright
10/13/20 Evercore ISI
Compass Pathways initiated with an Outperform at Evercore ISI
10/13/20 Canaccord
Compass Pathways initiated with a Buy at Canaccord
10/13/20 Berenberg
Compass Pathways initiated with a Buy at Berenberg
INSM Insmed
$39.02 /

-0.8 (-2.01%)

11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
11/23/20 Evercore ISI
Insmed resumed with an Outperform at Evercore ISI
10/12/20 Stifel
Insmed resumed with a Buy at Stifel
04/23/20 JMP Securities
JMP reiterates $50 target on Insmed on planned COVID-19 trial
ALXN Alexion
$121.96 /

-2.03 (-1.64%)

11/20/20
Fly Intel: Top five analyst initiations
11/20/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/19/20 Bernstein
Alexion initiated with a Market Perform at Bernstein
11/05/20 Citi
Alexion price target raised to $157 from $145 at Citi
ENTA Enanta
$41.32 /

-1.5 (-3.50%)

11/24/20 RBC Capital
Enanta price target lowered to $45 from $52 at RBC Capital
11/24/20 Evercore ISI
Evercore cautious on Enanta into 2021, starts with Underperform
11/23/20 Evercore ISI
Enanta initiated with an Underperform at Evercore ISI
10/26/20 Roth Capital
Enanta price target raised to $107 from $104 at Roth Capital
NKTX Nkarta
$32.91 /

-1.23 (-3.60%)

10/06/20 Mizuho
Nkarta CFO departure should not impact shares, says Mizuho
08/04/20 Mizuho
Mizuho starts Nkarta with Buy rating, $34 price target
08/04/20 Evercore ISI
Nkarta initiated with an Outperform at Evercore ISI
08/04/20 Stifel
Nkarta initiated with a Buy at Stifel
HRC Hill-Rom
$94.86 /

-0.71 (-0.74%)

11/04/20
Fly Intel: Top five analyst downgrades
11/04/20
Hill-Rom cut to Hold at Needham, expecting 'lost year' in FY21
11/04/20 Needham
Hill-Rom downgraded to Hold from Buy at Needham
10/01/20 KeyBanc
Hill-Rom price target lowered to $115 from $138 at KeyBanc
DRNA Dicerna
$25.32 /

+0.79 (+3.22%)

08/07/20 H.C. Wainwright
Dicerna price target raised to $35 from $32 at H.C. Wainwright
07/01/20 Baird
Dicerna elevated to Fresh Pick at Baird
05/12/20 RBC Capital
Dicerna initiated with an Outperform at RBC Capital
05/11/20 Truist
Dicerna price target raised to $33 from $28 at SunTrust
ZBH Zimmer Biomet
$149.21 /

-0.79 (-0.53%)

11/09/20 SVB Leerink
Zimmer Biomet price target raised to $167 from $160 at SVB Leerink
11/09/20 Credit Suisse
Zimmer Biomet price target raised to $106 from $99 at Credit Suisse
11/09/20 Baird
Zimmer Biomet valuation discount to peers hard to justify, says at Baird
11/09/20 Oppenheimer
Zimmer Biomet price target raised to $155 from $150 at Oppenheimer
INCY Incyte
$84.52 /

+1.33 (+1.60%)

11/06/20 RBC Capital
Incyte price target lowered to $86 from $96 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/14/20 Mizuho
Oncology 'fertile ground for M&A activity,' says Mizuho
08/05/20 Mizuho
Incyte price target raised to $95 from $79 at Mizuho
MTEM Molecular Templates
$8.93 /

-0.18 (-1.98%)

09/08/20 Jefferies
Molecular Templates initiated with a Buy at Jefferies
08/07/20
Molecular Templates files $300M mixed securities shelf
05/12/20 Oppenheimer
Molecular Templates price target raised to $22 from $16 at Oppenheimer
03/25/20
Fly Intel: Top five analyst initiations
KOD Kodiak Sciences
$136.67 /

+1.14 (+0.84%)

11/30/20
Fly Intel: Top five analyst downgrades
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral on valuation at JPMorgan
11/30/20 JPMorgan
Kodiak Sciences downgraded to Neutral from Overweight at JPMorgan
11/16/20 Morgan Stanley
Morgan Stanley downgrades Kodiak to Equal Weight on lack of near-term catalysts
ICLR Icon
$194.85 /

+4.45 (+2.34%)

10/23/20 Deutsche Bank
Icon price target raised to $179 from $170 at Deutsche Bank
10/23/20 Mizuho
Icon price target raised to $217 from $195 at Mizuho
10/22/20 Credit Suisse
Icon price target raised to $235 from $230 at Credit Suisse
07/27/20 Truist
SunTrust raises price targets on select late-stage CROs
MCRB Seres Therapeutics
$27.58 /

-1.39 (-4.80%)

11/09/20 Oppenheimer
Seres Therapeutics price target raised to $38 from $34 at Oppenheimer
11/09/20 Piper Sandler
Seres Therapeutics price target raised to $49 from $40 at Piper Sandler
10/27/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
10/26/20 Oppenheimer
Seres Therapeutics price target raised to $34 from $29 at Oppenheimer
NVST Envista
$29.75 /

+0.14 (+0.47%)

10/30/20 JPMorgan
Envista price target raised to $30 from $28 at JPMorgan
10/30/20 Piper Sandler
Envista price target raised to $28 from $22 at Piper Sandler
07/31/20 Piper Sandler
Envista price target raised to $22 from $20 at Piper Sandler
06/16/20
Fly Intel: Top five analyst initiations
EXEL Exelixis
$19.16 /

-0.26 (-1.34%)

10/26/20 Piper Sandler
Exelixis could have successor to Cabometyx with XL092, says Piper Sandler
09/22/20 Morgan Stanley
Exelixis price target raised to $29 from $23 at Morgan Stanley
09/21/20 Piper Sandler
Exelixis price target raised to $33 from $30 at Piper Sandler
06/30/20 Piper Sandler
Exelixis' 2/3 Phase III Contact studies underway, says Piper Sandler
FATE Fate Therapeutics
$58.47 /

+0.54 (+0.93%)

11/24/20 Truist
Fate Therapeutics price target raised to $65 from $40 at Truist
11/09/20 Citi
Fate Therapeutics price target raised to $63 from $40 at Citi
11/08/20 Oppenheimer
Fate Therapeutics price target raised to $60 from $40 at Oppenheimer
11/06/20 Piper Sandler
Fate Therapeutics price target raised to $71 from $59 at Piper Sandler
FOLD Amicus
$22.94 /

-0.31 (-1.33%)

11/11/20 Berenberg
Biotechnology companies initiated at Berenberg
11/11/20 Berenberg
Amicus initiated with a Hold at Berenberg
11/06/20 Baird
Amicus price target raised to $25 from $20 at Baird
08/11/20 Citi
Amicus price target raised to $20 from $15 at Citi
COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
BHC Bausch Health
$18.58 /

-0.97 (-4.96%)

11/05/20 Piper Sandler
Bausch Health price target lowered to $25 from $26 at Piper Sandler
10/26/20 Barclays
Bausch Health price target raised to $29 from $28 at Barclays
09/17/20
Fly Intel: Top five analyst upgrades
09/17/20 BofA
Bausch Health upgraded to Neutral from Underperform at BofA
TBIO Translate Bio
$22.24 /

+2.9 (+14.99%)

10/04/20 Goldman Sachs
Translate Bio initiated with a Buy at Goldman Sachs
07/07/20 H.C. Wainwright
Translate Bio price target raised to $32 from $18 at H.C. Wainwright
07/06/20
Fly Intel: Top five analyst initiations
07/06/20 William Blair
Translate Bio initiated with an Outperform at William Blair
STRO Sutro Biopharma
$17.08 /

-0.02 (-0.12%)

11/06/20 Piper Sandler
Sutro Biopharma price target raised to $22 from $20 at Piper Sandler
09/02/20 Jefferies
Sutro Biopharma initiated with a Buy at Jefferies
07/16/20 Wells Fargo
Sutro Biopharma initiated with an Overweight at Wells Fargo
PRAX Praxis Precision Medicines
$40.94 /

+0.54 (+1.34%)

11/17/20 Piper Sandler
Praxis Precision clinical hold looks like 'formality,' says Piper Sandler
11/11/20
Fly Intel: Top five analyst initiations
11/11/20 Wedbush
Wedbush bullish on Praxis Precision Medicines, initiates with an Outperform
11/11/20 Wedbush
Praxis Precision Medicines initiated with an Outperform at Wedbush
ZBH Zimmer Biomet
$149.21 /

-0.79 (-0.53%)

STRO Sutro Biopharma
$17.08 /

-0.02 (-0.12%)

NVST Envista
$29.75 /

+0.14 (+0.47%)

MTEM Molecular Templates
$8.93 /

-0.18 (-1.98%)

MCRB Seres Therapeutics
$27.58 /

-1.39 (-4.80%)

KOD Kodiak Sciences
$136.67 /

+1.14 (+0.84%)

INSM Insmed
$39.02 /

-0.8 (-2.01%)

INCY Incyte
$84.52 /

+1.33 (+1.60%)

ICLR Icon
$194.85 /

+4.45 (+2.34%)

HRC Hill-Rom
$94.86 /

-0.71 (-0.74%)

FOLD Amicus
$22.94 /

-0.31 (-1.33%)

FATE Fate Therapeutics
$58.47 /

+0.54 (+0.93%)

EXEL Exelixis
$19.16 /

-0.26 (-1.34%)

ENTA Enanta
$41.32 /

-1.5 (-3.50%)

DRNA Dicerna
$25.32 /

+0.79 (+3.22%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

CMPS Compass Pathways
$49.60 /

+2.26 (+4.77%)

BHC Bausch Health
$18.58 /

-0.97 (-4.96%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

  • 02
    Dec
  • 18
    Nov
  • 16
    Oct
  • 18
    Sep
  • 13
    Aug
  • 10
    Jul
  • 26
    Jun
  • 09
    Jun
  • 12
    May
  • 05
    May
  • 04
    Dec
TBIO Translate Bio
$22.24 /

+2.9 (+14.99%)

FOLD Amicus
$22.94 /

-0.31 (-1.33%)

CMPS Compass Pathways
$49.60 /

+2.26 (+4.77%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

TBIO Translate Bio
$22.24 /

+2.9 (+14.99%)

STRO Sutro Biopharma
$17.08 /

-0.02 (-0.12%)

PRAX Praxis Precision Medicines
$40.94 /

+0.54 (+1.34%)

NVST Envista
$29.75 /

+0.14 (+0.47%)

NKTX Nkarta
$32.91 /

-1.23 (-3.60%)

MTEM Molecular Templates
$8.93 /

-0.18 (-1.98%)

MCRB Seres Therapeutics
$27.58 /

-1.39 (-4.80%)

KOD Kodiak Sciences
$136.67 /

+1.14 (+0.84%)

FOLD Amicus
$22.94 /

-0.31 (-1.33%)

ENTA Enanta
$41.32 /

-1.5 (-3.50%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

BHC Bausch Health
$18.58 /

-0.97 (-4.96%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

STRO Sutro Biopharma
$17.08 /

-0.02 (-0.12%)

MCRB Seres Therapeutics
$27.58 /

-1.39 (-4.80%)

INCY Incyte
$84.52 /

+1.33 (+1.60%)

CMPS Compass Pathways
$49.60 /

+2.26 (+4.77%)

BHC Bausch Health
$18.58 /

-0.97 (-4.96%)

ALXN Alexion
$121.96 /

-2.03 (-1.64%)

On The Fly
Fly Intel: After-Hours Movers » 18:26
11/30/20
11/30
18:26
11/30/20
18:26
NCNA

NuCana

$4.49 /

-0.01 (-0.22%)

, TSLA

Tesla

$567.00 /

-18.77 (-3.20%)

, MRNA

Moderna

$152.93 /

+25.97 (+20.46%)

, NOAH

Noah Holdings

$29.53 /

-4.12 (-12.24%)

, ZM

Zoom Video

$479.28 /

+7.98 (+1.69%)

, ARRY

Array Technologies

$45.29 /

-1.86 (-3.94%)

, DADA

Dada Nexus

$57.97 /

+2.3899 (+4.30%)

, COGT

Cogent Biosciences

$10.02 /

+0.23 (+2.35%)

, FOUR

Shift4 Payments

$61.23 /

-0.43 (-0.70%)

, OSH

Oak Street Health

$47.17 /

+0.17 (+0.36%)

, NOVA

Sunnova Energy

$40.52 /

-4.43 (-9.86%)

, NTLA

Intellia Therapeutics

$39.28 /

-0.07 (-0.18%)

Check out this evening's…

ShowHide Related Items >><<
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

TSLA Tesla
$567.00 /

-18.77 (-3.20%)

OSH Oak Street Health
$47.17 /

+0.17 (+0.36%)

NTLA Intellia Therapeutics
$39.28 /

-0.07 (-0.18%)

NOVA Sunnova Energy
$40.52 /

-4.43 (-9.86%)

NOAH Noah Holdings
$29.53 /

-4.12 (-12.24%)

NCNA NuCana
$4.49 /

-0.01 (-0.22%)

MRNA Moderna
$152.93 /

+25.97 (+20.46%)

FOUR Shift4 Payments
$61.23 /

-0.43 (-0.70%)

DADA Dada Nexus
$57.97 /

+2.3899 (+4.30%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

ARRY Array Technologies
$45.29 /

-1.86 (-3.94%)

NCNA NuCana
$4.49 /

-0.01 (-0.22%)

11/24/20 H.C. Wainwright
NuCana price target lowered to $15 from $17 at H.C. Wainwright
10/22/20 Truist
NuCana initiated with a Buy at Truist
10/22/20 Truist
NuCana initiated with a Buy at Truist
08/21/20 Piper Sandler
NuCana price target raised to $17 from $15 at Piper Sandler
TSLA Tesla
$567.00 /

-18.77 (-3.20%)

11/27/20 BofA
BofA positive on long-term share gains for NIO Inc. after hosting calls
11/18/20
Fly Intel: Top five analyst upgrades
11/18/20 Morgan Stanley
Morgan Stanley upgrades Tesla on 'profound model shift' to recurring sales
11/18/20 Morgan Stanley
Tesla upgraded to Overweight from Equal Weight at Morgan Stanley
MRNA Moderna
$152.93 /

+25.97 (+20.46%)

11/30/20 Wells Fargo
Moderna price target raised to $129 from $92 at Wells Fargo
11/27/20 Argus
AstraZeneca's COVID vaccine faces high bar for FDA authorization, says Argus
11/25/20 Goldman Sachs
Moderna price target raised to $139 from $107 at Goldman Sachs
11/23/20
Fly Intel: Top five analyst initiations
NOAH Noah Holdings
$29.53 /

-4.12 (-12.24%)

07/10/20 Citi
Citi boosts Noah Holdings target, opens 'positive catalyst watch'
03/30/20 Citi
Noah Holdings upgraded to Buy from Neutral at Citi
02/11/20 Citi
Citi downgrades Noah Holdings to Neutral on coronavirus vulnerability
02/11/20 Citi
Noah Holdings downgraded to Neutral from Buy at Citi
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

11/30/20 Northland
Plantronics price target raised to $40 from $30 at Northland
11/25/20 Stifel
Stifel says Salesforce for Slack at $20B would be 'expensive,' but 'digestible'
11/10/20 Mizuho
Zoom Video selloff yesterday a buying opportunity, says Mizuho
10/26/20 Stifel
SAP news impact may be company-specific for software sector, says Stifel
ARRY Array Technologies
$45.29 /

-1.86 (-3.94%)

11/09/20
Fly Intel: Top five analyst initiations
11/09/20 Morgan Stanley
Array Technologies initiated with an Underweight at Morgan Stanley
11/09/20 UBS
Array Technologies initiated with a Neutral at UBS
11/09/20 Oppenheimer
Array Technologies initiated with a Perform at Oppenheimer
DADA Dada Nexus
$57.97 /

+2.3899 (+4.30%)

11/11/20
Fly Intel: Top five analyst upgrades
11/11/20 Goldman Sachs
Goldman Sachs upgrades Dada Nexus to Buy on online grocery adoption in China
11/11/20 Goldman Sachs
Dada Nexus upgraded to Buy from Neutral at Goldman Sachs
10/29/20 New Street
Dada Nexus initiated with a Buy at New Street
COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
FOUR Shift4 Payments
$61.23 /

-0.43 (-0.70%)

10/14/20 Truist
Shift4 Payments price target raised to $70 from $60 at Truist
10/14/20 Compass Point
Shift4 Payments upgraded to Neutral after pre-announcement at Compass Point
10/14/20 Compass Point
Shift4 Payments upgraded to Neutral from Sell at Compass Point
10/08/20 RBC Capital
Shift4 Payments price target raised to $63 from $49 at RBC Capital
OSH Oak Street Health
$47.17 /

+0.17 (+0.36%)

11/11/20 Piper Sandler
Oak Street Health price target raised to $59 from $54 at Piper Sandler
11/11/20 SVB Leerink
Oak Street Health price target raised to $78 from $55 at SVB Leerink
11/11/20 Baird
Oak Street Health price target raised to $60 from $55 at Baird
10/13/20 Truist
Truist raises price targets on select Healthcare Services names
NOVA Sunnova Energy
$40.52 /

-4.43 (-9.86%)

11/09/20 Goldman Sachs
Sunnova Energy upgraded to Conviction Buy from Buy at Goldman Sachs
10/27/20 B. Riley Securities
Sunnova Energy price target raised to $33 from $30 at B. Riley Securities
10/26/20 Credit Suisse
Sunnova Energy price target raised to $38 from $26 at Credit Suisse
10/22/20 Baird
Baird a buyer of solar stocks insulated from supply chain disruptions
NTLA Intellia Therapeutics
$39.28 /

-0.07 (-0.18%)

10/27/20 Truist
Intellia Therapeutics initiated with a Buy at Truist
10/27/20 Summer Street
Intellia Therapeutics initiated with a Buy at Summer Street
10/19/20 Roth Capital
Intellia Therapeutics price target raised to $26 from $16 at Roth Capital
10/14/20
Fly Intel: Top five analyst initiations
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

TSLA Tesla
$567.00 /

-18.77 (-3.20%)

OSH Oak Street Health
$47.17 /

+0.17 (+0.36%)

NTLA Intellia Therapeutics
$39.28 /

-0.07 (-0.18%)

NOVA Sunnova Energy
$40.52 /

-4.43 (-9.86%)

NCNA NuCana
$4.49 /

-0.01 (-0.22%)

MRNA Moderna
$152.93 /

+25.97 (+20.46%)

FOUR Shift4 Payments
$61.23 /

-0.43 (-0.70%)

DADA Dada Nexus
$57.97 /

+2.3899 (+4.30%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

  • 03
    Dec
  • 03
    Dec
  • 01
    Dec
  • 02
    Dec
  • 02
    Dec
  • 15
    Oct
  • 17
    Sep
  • 11
    Sep
  • 14
    Aug
  • 06
    Aug
  • 01
    Jul
  • 03
    Jun
  • 05
    Jun
  • 05
    Jun
  • 19
    May
  • 14
    Feb
  • 12
    Feb
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

TSLA Tesla
$567.00 /

-18.77 (-3.20%)

MRNA Moderna
$152.93 /

+25.97 (+20.46%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

TSLA Tesla
$567.00 /

-18.77 (-3.20%)

OSH Oak Street Health
$47.17 /

+0.17 (+0.36%)

NTLA Intellia Therapeutics
$39.28 /

-0.07 (-0.18%)

NOVA Sunnova Energy
$40.52 /

-4.43 (-9.86%)

NCNA NuCana
$4.49 /

-0.01 (-0.22%)

MRNA Moderna
$152.93 /

+25.97 (+20.46%)

FOUR Shift4 Payments
$61.23 /

-0.43 (-0.70%)

DADA Dada Nexus
$57.97 /

+2.3899 (+4.30%)

ARRY Array Technologies
$45.29 /

-1.86 (-3.94%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

TSLA Tesla
$567.00 /

-18.77 (-3.20%)

OSH Oak Street Health
$47.17 /

+0.17 (+0.36%)

NOVA Sunnova Energy
$40.52 /

-4.43 (-9.86%)

NOAH Noah Holdings
$29.53 /

-4.12 (-12.24%)

MRNA Moderna
$152.93 /

+25.97 (+20.46%)

FOUR Shift4 Payments
$61.23 /

-0.43 (-0.70%)

ARRY Array Technologies
$45.29 /

-1.86 (-3.94%)

Syndicate
Cogent Biosciences announces $60M common stock offering » 16:03
11/30/20
11/30
16:03
11/30/20
16:03
COGT

Cogent Biosciences

$10.02 /

+0.23 (+2.35%)

Cogent Biosciences…

Cogent Biosciences announced that it has commenced an underwritten public offering of $60M of shares of its common stock. Cogent Biosciences intends to use the net proceeds from the offering for development, regulatory and commercial preparation activities relating to PLX9486 and other product candidates, as well as for working capital and general corporate purposes. Jefferies and Piper Sandler & Co. are acting as joint book-running managers for the offering. Wedbush PacGrow, LifeSci Capital, and Ladenburg Thalmann are also acting as co-managers for the offering.

ShowHide Related Items >><<
COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
COGT Cogent Biosciences
$10.02 /

+0.23 (+2.35%)

Hot Stocks
Cogent Biosciences appoints Brad Barnett as Chief Technology Officer » 07:01
11/30/20
11/30
07:01
11/30/20
07:01
COGT

Cogent Biosciences

$9.60 /

+0.15 (+1.59%)

Cogent Biosciences…

Cogent Biosciences announced the appointment of Brad Barnett as Chief Technology Officer. In his new role, Barnett will be responsible for all aspects of chemistry, manufacturing and controls,, technical development, supply chain operations, and alliance management. "We are excited to welcome Brad to the growing Cogent Biosciences team. Brad's extensive experience leading the manufacturing and supply chain organization at Array BioPharma will prove invaluable as we expand PLX9486 into clinical trials for systemic mastocytosis and gastrointestinal stromal tumor patients," said Andrew Robbins, President & CEO of Cogent Biosciences. "I had the pleasure of working with Brad at Array, and I am excited to reconnect as we execute on our development plans for PLX9486. Additionally, Brad will be a great asset to our team as we look to the future of the company including building a portfolio of new, selective, and potent precision medicines around our lead asset PLX9486."

ShowHide Related Items >><<
COGT Cogent Biosciences
$9.60 /

+0.15 (+1.59%)

COGT Cogent Biosciences
$9.60 /

+0.15 (+1.59%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
COGT Cogent Biosciences
$9.60 /

+0.15 (+1.59%)

Hot Stocks
Cogent Biosciences reports final Phase 2 results from PLX9486 in GIST » 09:04
11/18/20
11/18
09:04
11/18/20
09:04
COGT

Cogent Biosciences

$9.70 /

-0.4 (-3.96%)

Cogent Biosciences…

Cogent Biosciences announced the final results from its PLX9486 + sunitinib Phase 1/2 study in patients with advanced gastrointestinal stromal tumors, or GIST. PLX9486 is a selective tyrosine kinase inhibitor designed to potently inhibit KIT exon 17 mutations, including D816V. Most patients with imatinib-resistant GIST have both primary and secondary KIT mutations. These data suggest that treatment with a combination of PLX9486 and sunitinib may provide substantial clinical benefit over treatment with type I or type II inhibitors alone. A majority of patients treated with PLX9486 + sunitinib experienced clinical benefit with a median PFS of 12 months and 20% ORR, including a complete response, in a heavily pre-treated GIST population; 27% of patients remain on therapy out 27-34 months. The combination showed no dose limiting toxicities and no maximum tolerated dose was reached. Single agent ctDNA analysis supports PLX9486 specificity and demonstrates clinical activity against KIT exon 17 mutation. A Phase 3 GIST trial initiation is planned for 2H 2021.

ShowHide Related Items >><<
COGT Cogent Biosciences
$9.70 /

-0.4 (-3.96%)

COGT Cogent Biosciences
$9.70 /

-0.4 (-3.96%)

11/10/20 Wedbush
Cogent Biosciences price target raised to $24 from $6 at Wedbush
10/14/20 Ladenburg
Ladenburg starts Cogent Biosciences with Buy, $4 price target
10/14/20 Ladenburg
Cogent Biosciences initiated with a Buy at Ladenburg
COGT Cogent Biosciences
$9.70 /

-0.4 (-3.96%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.